Debjani(Mondal)SahniMD

Assistant Professor of Dermatology, Boston University School of Medicine

Dr. Sahni is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
725 Albany St
# Shapiro
Boston, MA 02118
Phone+1 617-638-7420

Fax+1 617-638-7289

Massachusetts General Hospital/Beth Israel Deaconess Medical Center/Brigham and Women's HospResidency, Dermatology, 2007 - 2008
SUNY Downstate Health Sciences UniversityResidency, Internal Medicine, 2001 - 2001
Guy's, King's and St Thomas' School of Medical EducationClass of 1998

PubMed

13 citations
Early Detection and Prognostic Assessment of Cutaneous Melanoma: Consensus on Optimal Practice and the Role of Gene Expression Profile Testing.
Mohammed Kashani-Sabet, Sancy A Leachman, Jennifer A Stein, Jack L Arbiser, Elizabeth G Berry
JAMA Dermatology. 2023-05-01
18 citations
Racial and ethnic disparities in melanoma awareness: A cross-sectional survey.
Daniela P. Sanchez, Mayra B.C. Maymone, Emily O. McLean, Kevin F. Kennedy, Debjani Sahni
Journal of the American Academy of Dermatology. 2020-10-01
23 citations
Chemoprevention agents for melanoma: A path forward into phase 3 clinical trials.
Joanne M. Jeter, Tawnya L. Bowles, Clara Curiel-Lewandrowski, Susan M. Swetter, Fabian V. Filipp
Cancer. 2019-01-01

Lectures

Novel Therapies for Cutaneous Malignancies: What's New and What's Ahead
American Academy of Dermatology - Annual Meeting 2019 - Washington, D.C. - 3/2/2019

What's Fact and Fiction About Sun Safety in the Summer of a Total EclipseMay 30th, 2017